Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants After Stent Implantation.
Kunadian V., Dunford JR., Swarbrick D., Halaby R., Ajari O., Cochet M., Feeney K., Larkin E., Gonzalez GR., Govindavarjhulla A., Nethala D., Patel H., Guddeti RR., Khan F., Kumar S., Patel S., Saddala P., Serla VV., Zacarkim M., Yadav D., Gibson CM.
Triple oral anticoagulation or triple antiplatelet therapies may be administered for various reasons. They reduce cardiac complications following percutaneous coronary intervention and stroke or other thromboembolic phenomenon in conditions such as atrial fibrillation. There is an elevated risk of severe bleeding, so it is necessary to balance risk and benefits. Newer oral anticoagulants and antiplatelet drugs may be considered; the number of options is increasing. This article examines triple therapies and the efficacy and safety of combinations of traditional anticoagulant and antiplatelet drugs, and reviews clinical trial data on novel agents. Guidelines to inform clinical decision-making are presented.